COLLEEN MAGAI: Open Payments
NPI 1851346225 · FULTONVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,277 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,322 · 2025 $2,277
Food & beverage: $2,277
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $495 |
| Novo Nordisk Inc | 3 | $371 |
| ABBVIE INC. | 3 | $364 |
| Amgen Inc. | 3 | $360 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $249 |
| Janssen Biotech, Inc. | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $118 |
| Alkermes, Inc. | 1 | $28 |
| Indivior Inc. | 1 | $23 |
Products named: BREZTRI, JARDIANCE, Wegovy, RYBREVANT, NEFFY, EMBLAVEO, AIRSUPRA, UBRELVY.
Industry payments across NY — which companies pay providers there.
